Biotech

Category / Pharmaceuticals & Biotech / Biotech

Agile Therapeutics Announces FDA Accepts New Drug Application for Its Low-Dose, Once-Weekly Contraceptive Patch

PRINCETON, NJ: Response From FDA Expected in Q1 2013 ...

Paladin Labs Completes Strategic Partnership Transaction With Litha

MONTREAL, CANADA: ...

Corcept Therapeutics Announces Underwritten Public Offering of Common Stock

MENLO PARK, CA: ...

Dynavax Reports New CPT Code for Adult Two Dose Hepatitis B Vaccination Schedule

BERKELEY, CA: ...

FDA Approves Cornerstone Therapeutics' ANDA for Generic Tussionex(R) Pennkinetic(R) Product

CARY, NC: ...

The Medicines Company Expects Cangrelor Phase 3 Trial Enrollment Completion in 2012

PARSIPPANY, NJ: Review Committee Recommends Sample Size of 10,900 Patients Based on Interim Analysis ...

Corcept Therapeutics Commences Public Offering of Common Stock

MENLO PARK, CA: ...

Horizon Pharma to Present at the 7th Annual JMP Securities Healthcare Conference

DEERFIELD, IL: ...

Actelion Pharmaceuticals Announces U.S. Food and Drug Administration Approval of Supplemental New Drug Application for Second Generation VELETRI(R) (epoprostenol) for Injection

SOUTH SAN FRANCISCO, CA: Newly Approved Formulation of VELETRI(R) Will Be Commercially Available in Q3 2012 ...

International Stem Cell Corporation Reports Reaching Milestone in Its Cornea Program

CARLSBAD, CA: ...

Lorus Therapeutics Announces Issuance of Canadian Patent for Novel Anticancer Therapy IL-17E

TORONTO, ONTARIO: ...

BioCentury Wins Mediscience Commentator of the Year Award

REDWOOD CITY, CA: ...

Hepregen Corporation Receives National Science Foundation Grant Under SBIR Phase II-B Program

MEDFORD, MA: Grant Funding Will Support Continued Development of HepatoPac(TM) for Advanced Toxicity Screening and Drug Discovery ...

MethylGene Announces the Appointment of Dr. Rodney Lappe to its Board of Directors

MONTREAL, CANADA: ...

IBEX Reports Results for the Nine Months Ended April 30, 2012

MONTREAL, QUEBEC: ...

Cornerstone Therapeutics Completes Acquisition of EKR Therapeutics

CARY, NC: ...

Kedem Pharmaceuticals to Appoint New Chief Operating Officer

VANCOUVER, BRITISH COLUMBIA: ...

New Phase II, NIH-sponsored Study Demonstrates Metabolic Effects of Tesamorelin in Obese Subjects With Reduced Growth Hormone Secretion

MONTREAL, CANADA: Study results presented at 94th Annual Meeting of the Endocrine Society, Houston, Texas, Tuesday, June 26, 2012 ...

Astellas and Medivation Announce European Regulatory Submission for Enzalutamide for the Treatment of Men With Advanced Prostate Cancer Post-Chemotherapy

SAN FRANCISCO, CA and TOKYO: Submission Based on Pivotal Phase 3 Affirm Study ...

ProMetic Receives $4.6 Million Purchase Order From Octapharma

LAVAL, QUEBEC, CANADA: - Purchase order triggers $1.1 million upfront payment - Shipments during the second half of 2012 to exceed $2.0 million ...

Page 191 von 247: 1 « .. 190 191 192 193 194 195 196 197 198 199 .. » 247

All members:	10 567
Register today:	2
Register yesterday:	0
Members online:	0
Guests online:	118